Domainex announced a collaboration on exciting drug discovery programmes with the Breakthrough Breast Cancer Research Centre and The Institute of Cancer Research

Domainex announced a collaboration on exciting drug discovery programmes with the Breakthrough Breast Cancer Research Centre and The Institute of Cancer Research to identify and develop inhibitors of two recently validated breast cancer targets, tankyrase and IKK-epsilon.

Download press release